- Home
- TMO vs PFE Comparison
TMO vs PFE Comparison
Compare TMO & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMO
- PFE
- Stock Information
- Founded
- TMO 1956
- PFE 1849
- Country
- TMO United States
- PFE United States
- Employees
- TMO N/A
- PFE N/A
- Industry
- TMO Industrial Machinery/Components
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- TMO Industrials
- PFE Health Care
- Exchange
- TMO Nasdaq
- PFE Nasdaq
- Market Cap
- TMO 159.1B
- PFE 142.5B
- IPO Year
- TMO N/A
- PFE N/A
- Fundamental
- Price
- TMO $500.22
- PFE $25.87
- Analyst Decision
- TMO Buy
- PFE Hold
- Analyst Count
- TMO 17
- PFE 12
- Target Price
- TMO $583.25
- PFE $29.36
- AVG Volume (30 Days)
- TMO 2.3M
- PFE 43.9M
- Earning Date
- TMO 07-23-2025
- PFE 08-05-2025
- Dividend Yield
- TMO 0.34%
- PFE 6.65%
- EPS Growth
- TMO 7.24
- PFE N/A
- EPS
- TMO 17.30
- PFE 1.89
- Revenue
- TMO $43,212,000,000.00
- PFE $63,833,000,000.00
- Revenue This Year
- TMO $3.28
- PFE N/A
- Revenue Next Year
- TMO $4.81
- PFE N/A
- P/E Ratio
- TMO $28.91
- PFE $13.66
- Revenue Growth
- TMO 2.04
- PFE 13.53
- 52 Week Low
- TMO $385.46
- PFE $20.92
- 52 Week High
- TMO $627.88
- PFE $30.43
- Technical
- Relative Strength Index (RSI)
- TMO 65.61
- PFE 65.14
- Support Level
- TMO $482.81
- PFE $24.47
- Resistance Level
- TMO $500.93
- PFE $25.30
- Average True Range (ATR)
- TMO 9.98
- PFE 0.43
- MACD
- TMO 0.81
- PFE 0.15
- Stochastic Oscillator
- TMO 96.13
- PFE 89.33
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.